Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2

Abstract

Although further studies are needed to clarify the exact management of patients with a mutation in each gene, this study highlights information that can be captured with panel testing and provides support for incorporation of panel testing into clinical practice.